Purpose: We compared the effects of exercise intensity (EI) on the cytokine response to an acute bout of running.
Methods: Ten males (mean ± SD V˙O2max = 56.2 ± 8.1 mL·min−1·kg−1) completed three, counterbalanced, 8-d trials. After three control days, on day 4, participants completed 60 min of running at 55%, 65%, and 75% V˙O2max. The cytokines tumor necrosis factor (TNF)-α, interleukin-1β (IL-1β), IL-6, and IL-1 receptor antagonist (ra), and creatine kinase were measured during and for 3 h after exercise and on four follow-up days (FU1–FU4).
Results: RER was higher at 75% V˙O2max compared with both 55% (P < 0.001) and 65% (P < 0.01) V˙O2max. IL-1β was undetectable in six participants. There was a small (18%–27%) increase in TNF-α during exercise but no effect of EI. IL-6 concentrations peaked at the end of exercise, with a greater increase at 75% V˙O2max, resulting in higher concentrations at the end of exercise and at 30 min after exercise compared with 55% (P < 0.001) and 65% V˙O2max (P < 0.01). IL-1ra concentrations peaked at the end of exercise at 75% V˙O2max, resulting in higher (P < 0.05) concentrations at 1–2 h after exercise compared with 55% and 65% V˙O2max. Creatine kinase was increased at FU1 and FU2, but there was no effect of EI.
Conclusions: Sixty minutes of treadmill running at 75% V˙O2max results in a greater increase in IL-6 but not TNF-α compared with 55% and 65% V˙O2max. The higher IL-1ra concentrations at 75% V˙O2max might be related to the higher IL-6 concentrations that precede them.
1Human Protection and Performance Enhancement, QinetiQ, Farnborough, UNITED KINGDOM; 2Biomedical, Life, and Health Sciences Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, UNITED KINGDOM; 3Plans Branch, HQ Army Recruiting and Training Division, Upavon, UNITED KINGDOM; 4Department of Musculoskeletal Biology, University of Liverpool, Liverpool, UNITED KINGDOM; and 5Department of Medicine, Norwich Medical School, University of East Anglia, Norwich, UNITED KINGDOM
Address for correspondence: Craig Sale, Ph.D., Biomedical, Life and Health Sciences Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom; E-mail: firstname.lastname@example.org.
Submitted for publication March 2011.
Accepted for publication April 2011.